The China question is tearing biotech apart Its ascent is forcing U.S. firms and investors to pick a side: Is the country an ally or an existential threat?

https://www.statnews.com/2026/05/18/biotech-industry-split-chinese-drugs-opportunity-versus-existential-threat/ By Damian GardeMay 18, 2026 Garde, who has covered biotech for nearly 15 years, spoke with more than a dozen investors, entrepreneurs, and industry leaders about how China has caused a rift between peers and partners.